Antenatal corticosteroids in pregnancies complicated by preterm premature rupture of membranes

Obstetrics and Gynecology

Volumn 90, Issue 5, 1997, Pages 851-853

  Gardner, Michael O ^a   Papile, Lu Ann ^b   Wright, Linda L ^b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

ARTICLE; BRAIN HEMORRHAGE; CORTICOSTEROID THERAPY; FETUS LUNG MATURATION; HUMAN; INFECTION RISK; MEDICAL DECISION MAKING; NEWBORN INFECTION; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; TREATMENT PLANNING;

ADRENAL CORTEX HORMONES; CEREBRAL HEMORRHAGE; CONSENSUS DEVELOPMENT CONFERENCES, NIH; DECISION SUPPORT TECHNIQUES; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; PREGNANCY; RISK FACTORS; SEPSIS; UNITED STATES;

EID: 0030821715     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(97)00404-3     Document Type: Article

References (13)

1. National Institutes of Health Consensus Statement. Effect of corticosteroids for fetal maturation on perinatal outcomes. Bethesda, Maryland: National Institutes of Health 1994;12:1-19.
2. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. Antenatal corticosteroid therapy for fetal maturation. ACOG committee opinion no. 147. Washington, DC: American College of Obstetricians and Gynecologists, 1994.
3. Kennedy KA, Clark SL. Premature rupture of the membranes: Management controversies. Clin Perinatol 1992;19:385-97.
4. Wright LL, Horbar JD, Gunkel H, Verter J, Younes N, Andrew EB, et al. Evidence from multicenter networks on the current use and effectiveness of antenatal corticosteroids in low birth weight infants. Am J Obstet Gynecol 1995;173:263-9.
5. Gunkel JH, Mitchell BR. Observational evidence for the efficacy of antenatal steroids from randomized studies of surfactant replacement. Am J Obstet Gynecol 1995;173:281-5.
6. Crowley P. Update on the antenatal steroid meta-analysis. Am J Obstet Gynecol 1995;173:322-35.
7. Wright LL, Verter J, Younes N, Stevenson D, Fanaroff A, Shankaran S, et al. Antenatal corticosteroid administration and neonatal outcome in very low birth weight infants: The NICHD Neonatal Research Network. Am J Obstet Gynecol 1995;173:269-74.
8. Morales WJ, Diebel D, Lazar AJ, Zadrozny D. The effect of antenatal dexamethasone administration on the prevention of respiratory distress syndrome in preterm gestations with premature rupture of membranes. Am J Obstet Gynecol 1986;154:591-5.
9. Gardner MO, Bronstein J, Goldenberg RL, Haywood JL, Cliver SP, Nelson KG. Physician opinions of preterm infant outcome and their effect on antenatal corticosteroid use. J Perinatol 1996;16: 431-4.
10. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evaluation of subependymal and intraventricular hemorrhage: A study of infants with birthweights less than 1,500 grams. J Pediatr 1978;92:529-34.
11. Volpe JJ. Neurology of the newborn. 3rd ed. Philadelphia: WB Saunders, 1995.
12. Stoll B, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, et al. Early onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996;129:72-80.
13. Lewis DF, Brody K, Edwards M, Brouillette RM, Burlison S, London SN. Preterm premature ruptured membranes: A randomized trial of steroids after treatment with antibiotics. Obstet Gynecol 1996;88:801-5.